NIH researchers Dr. Sarah A. Rudzinskas and Sarah Spector guest on this SheSez episode sharing about studies they are helping conduct for a new drug aimed at helping women in midlife who suffer from depression-often for the first time in their lives.
An estimated 20% of American women have depression at some point during menopause; and 38% experience depression in late menopause. The researchers are exploring the link between low levels of estrogen and depression and how those levels impact the brain—which this new drug, manufactured by the pharmaceutical company Eli Lily, addresses.
Women interested in being part of the NIH study can click here for more information.
